The dual role of astrocyte activation and reactive gliosis

Neuroscience Letters

Volumn 565, Issue , 2014, Pages 30-38

  Pekny, Milos ^a,b   Wilhelmsson, Ulrika ^a   Pekna, Marcela ^a,b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

Author keywords

Alzheimer's disease; Astrogliosis; CNS injury; GFAP; Intermediate filaments (nanofilaments); Ischemic stroke; Neural plasticity and regeneration

Indexed keywords

INTERMEDIATE FILAMENT PROTEIN;

ALZHEIMER DISEASE; ASTROCYTE; BRAIN ISCHEMIA; CELL ACTIVATION; CELL DAMAGE; CELL ISOLATION; CELL STRESS; CENTRAL NERVOUS SYSTEM; CEREBROVASCULAR ACCIDENT; DEGENERATIVE DISEASE; EPILEPSY; EXPERIMENTAL MODEL; GLIOSIS; HOMEOSTASIS; INTERMEDIATE FILAMENT; MICROGLIA; NERVE CELL PLASTICITY; NERVE DEGENERATION; NERVE REGENERATION; NEUROLOGIC DISEASE; NEUROMODULATION; NEUROPROTECTION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REACTIVE GLIOSIS; REVIEW; SEX DIFFERENCE; SYNAPTIC INHIBITION;

ALZHEIMER'S DISEASE; ASTROGLIOSIS; CNS INJURY; GFAP; INTERMEDIATE FILAMENTS (NANOFILAMENTS); ISCHEMIC STROKE; NEURAL PLASTICITY AND REGENERATION;

ANIMALS; ASTROCYTES; BRAIN INJURIES; BRAIN ISCHEMIA; CELL COMMUNICATION; FEMALE; GLIOSIS; HUMANS; MALE; MICROGLIA; NERVE DEGENERATION; SEX FACTORS; SPINAL INJURIES;

EID: 84897095899     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2013.12.071     Document Type: Review

References (160)

1. Ullian E.M., Sapperstein S.K., Christopherson K.S., Barres B.A. Control of synapse number by glia. Science 2001, 291:657-661.
2. Ullian E.M., Christopherson K.S., Barres B.A. Role for glia in synaptogenesis. Glia 2004, 47:209-216.
3. Christopherson K.S., Ullian E.M., Stokes C.C., Mullowney C.E., Hell J.W., Agah A., Lawler J., Mosher D.F., Bornstein P., Barres B.A. Thrombospondins are astrocyte-secreted proteins that promote CNS synaptogenesis. Cell 2005, 120:421-433.
4. Eroglu C., Barres B.A. Regulation of synaptic connectivity by glia. Nature 2010, 468:223-231.
5. Choi H.B., Gordon G.R., Zhou N., Tai C., Rungta R.L., Martinez J., Milner T.A., Ryu J.K., McLarnon J.G., Tresguerres M., Levin L.R., Buck J., MacVicar.B.A. Metabolic communication between astrocytes and neurons via bicarbonate-responsive soluble adenylyl cyclase. Neuron 2012, 75:1094-1104.
6. Pellerin L., Bouzier-Sore A.K., Aubert A., Serres S., Merle M., Costalat R., Magistretti P.J. Activity-dependent regulation of energy metabolism by astrocytes: an update. Glia 2007, 55:1251-1262.
7. Rouach N., Koulakoff A., Abudara V., Willecke K., Giaume C. Astroglial metabolic networks sustain hippocampal synaptic transmission. Science 2008, 322:1551-1555.
8. Simard M., Nedergaard M. The neurobiology of glia in the context of water and ion homeostasis. Neuroscience 2004, 129:877-896.
9. Suzuki A., Stern S.A., Bozdagi O., Huntley G.W., Walker R.H., Magistretti P.J., Alberini C.M. Astrocyte-neuron lactate transport is required for long-term memory formation. Cell 2011, 144:810-823.
10. Barres B.A. The mystery and magic of glia: a perspective on their roles in health and disease. Neuron 2008, 60:430-440.
11. Liebner S., Czupalla C.J., Wolburg H. Current concepts of blood-brain barrier development. Int. J. Dev. Biol. 2011, 55:467-476.
12. Attwell D., Buchan A.M., Charpak S., Lauritzen M., Macvicar B.A., Newman E.A. Glial and neuronal control of brain blood flow. Nature 2010, 468:232-243.
13. Mulligan S.J., MacVicar.B.A. Calcium transients in astrocyte endfeet cause cerebrovascular constrictions. Nature 2004, 431:195-199.
14. Zonta M., Angulo M.C., Gobbo S., Rosengarten B., Hossmann K.A., Pozzan T., Carmignoto G. Neuron-to-astrocyte signaling is central to the dynamic control of brain microcirculation. Nat. Neurosci. 2003, 6:43-50.
15. Kosaka T., Hama K. Three-dimensional structure of astrocytes in the rat dentate gyrus. J. Comp. Neurol. 1986, 249:242-260.
16. Grosche J., Matyash V., Moller T., Verkhratsky A., Reichenbach A., Kettenmann H. Microdomains for neuron-glia interaction: parallel fiber signaling to Bergmann glial cells. Nat. Neurosci. 1999, 2:139-143.
17. Bushong E.A., Martone M.E., Jones Y.Z., Ellisman M.H. Protoplasmic astrocytes in CA1 stratum radiatum occupy separate anatomical domains. J. Neurosci. 2002, 22:183-192.
18. Bushong E.A., Martone M.E., Ellisman M.H. Maturation of astrocyte morphology and the establishment of astrocyte domains during postnatal hippocampal development. Int. J. Dev. Neurosci. 2004, 22:73-86.
19. Haber M., Murai K.K. Reshaping neuron-glial communication at hippocampal synapses. Neuron Glia. Biol. 2006, 2:59-66.
20. Oberheim N.A., Takano T., Han X., He W., Lin J.H., Wang F., Xu Q., Wyatt J.D., Pilcher W., Ojemann J.G., Ransom B.R., Goldman S.A., Nedergaard M. Uniquely hominid features of adult human astrocytes. J. Neurosci. 2009, 29:3276-3287.
21. Matyash V., Kettenmann H. Heterogeneity in astrocyte morphology and physiology. Brain Res. Rev. 2010, 63:2-10.
22. Zhang Y., Barres B.A. Astrocyte heterogeneity: an underappreciated topic in neurobiology. Curr. Opin. Neurobiol. 2010, 20:588-594.
23. Bardehle S., Kruger M., Buggenthin F., Schwausch J., Ninkovic J., Clevers H., Snippert H.J., Theis F.J., Meyer-Luehmann M., Bechmann I., Dimou L., Gotz M. Live imaging of astrocyte responses to acute injury reveals selective juxtavascular proliferation. Nat. Neurosci. 2013, 16:580-586.
24. Beckervordersandforth R., Tripathi P., Ninkovic J., Bayam E., Lepier A., Stempfhuber B., Kirchhoff F., Hirrlinger J., Haslinger A., Lie D.C., Beckers J., Yoder B., Irmler M., Gotz M. In vivo fate mapping and expression analysis reveals molecular hallmarks of prospectively isolated adult neural stem cells. Cell Stem Cell 2010, 7:744-758.
25. Stahlberg A., Andersson D., Aurelius J., Faiz M., Pekna M., Kubista M., Pekny M. Defining cell populations with single-cell gene expression profiling: correlations and identification of astrocyte subpopulations. Nucleic Acids Res. 2011, 39:e24.
26. Zamanian J.L., Xu L., Foo L.C., Nouri N., Zhou L., Giffard R.G., Barres B.A. Genomic analysis of reactive astrogliosis. J. Neurosci. 2012, 32:6391-6410.
27. Balasingam V., Tejada-Berges T., Wright E., Bouckova R., Yong V.W. Reactive astrogliosis in the neonatal mouse brain and its modulation by cytokines. J. Neurosci. 1994, 14:846-856.
28. Klein M.A., Moller J.C., Jones L.L., Bluethmann H., Kreutzberg G.W., Raivich G. Impaired neuroglial activation in interleukin-6 deficient mice. Glia 1997, 19:227-233.
29. Rabchevsky A.G., Weinitz J.M., Coulpier M., Fages C., Tinel M., Junier M.P. A role for transforming growth factor alpha as an inducer of astrogliosis. J. Neurosci. 1998, 18:10541-10552.
30. Sriram K., Benkovic S.A., Hebert M.A., Miller D.B., O'Callaghan J.P. Induction of gp130-related cytokines and activation of JAK2/STAT3 pathway in astrocytes precedes up-regulation of glial fibrillary acidic protein in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of neurodegeneration: key signaling pathway for astrogliosis in vivo?. J. Biol. Chem. 2004, 279:19936-19947.
31. Winter C.G., Saotome Y., Levison S.W., Hirsh D. A role for ciliary neurotrophic factor as an inducer of reactive gliosis, the glial response to central nervous system injury. Proc. Natl. Acad. Sci. USA 1995, 92:5865-5869.
32. Eddleston M., Mucke L. Molecular profile of reactive astrocytes-implications for their role in neurologic disease. Neuroscience 1993, 54:15-36.
33. Eng L.F., Ghirnikar R.S. GFAP and astrogliosis. Brain Pathol. 1994, 4:229-237.
34. Eng L.F., Ghirnikar R.S., Lee Y.L. Glial fibrillary acidic protein: GFAP-thirty one years (1969-2000). Neurochem Res. 2000, 25:1439-1451.
35. Hernandez M.R., Agapova O.A., Yang P., Salvador-Silva M., Ricard C.S., Aoi S. Differential gene expression in astrocytes from human normal and glaucomatous optic nerve head analyzed by cDNA microarray. Glia 2002, 38:45-64.
36. Maragakis N.J., Rothstein J.D. Mechanisms of disease: astrocytes in neurodegenerative disease. Nat. Clin. Pract. Neurol. 2006, 2:679-689.
37. Seifert G., Schilling K., Steinhauser C. Astrocyte dysfunction in neurological disorders: a molecular perspective. Nat. Rev. Neurosci. 2006, 7:194-206.
38. Sofroniew M.V., Vinters H.V. Astrocytes: biology and pathology. Acta Neuropathol. 2010, 119:7-35.
39. Pekny M., Pekna M. Astrocyte intermediate filaments in CNS pathologies and regeneration. J. Pathol. 2004, 204:428-437.
40. Goritz C., Dias D.O., Tomilin N., Barbacid M., Shupliakov O., Frisen J. A pericyte origin of spinal cord scar tissue. Science 2011, 333:238-242.
41. Pekny M., Nilsson M. Astrocyte activation and reactive gliosis. Glia 2005, 50:427-434.
42. Sofroniew M.V. Molecular dissection of reactive astrogliosis and glial scar formation. Trends Neurosci. 2009, 32:638-647.
43. Delaney C.L., Brenner M., Messing A. Conditional ablation of cerebellar astrocytes in postnatal transgenic mice. J. Neurosci. 1996, 16:6908-6918.
44. Herrmann J.E., Imura T., Song B., Qi J., Ao Y., Nguyen T.K., Korsak R.A., Takeda K., Akira S., Sofroniew M.V. STAT3 is a critical regulator of astrogliosis and scar formation after spinal cord injury. J. Neurosci. 2008, 28:7231-7243.
45. Okada S., Nakamura M., Katoh H., Miyao T., Shimazaki T., Ishii K., Yamane J., Yoshimura A., Iwamoto Y., Toyama Y., Okano H. Conditional ablation of Stat3 or Socs3 discloses a dual role for reactive astrocytes after spinal cord injury. Nat. Med. 2006, 12:829-834.
46. Kerr B.J., Patterson P.H. Potent pro-inflammatory actions of leukemia inhibitory factor in the spinal cord of the adult mouse. Exp. Neurol. 2004, 188:391-407.
47. Xia X.G., Hofmann H.D., Deller T., Kirsch M. Induction of STAT3 signaling in activated astrocytes and sprouting septal neurons following entorhinal cortex lesion in adult rats. Mol. Cell. Neurosci. 2002, 21:379-392.
48. Gao Q., Wolfgang M.J., Neschen S., Morino K., Horvath T.L., Shulman G.I., Fu X.Y. Disruption of neural signal transducer and activator of transcription 3 causes obesity, diabetes, infertility, and thermal dysregulation. Proc. Natl. Acad. Sci. USA 2004, 101:4661-4666.
49. Mori H., Hanada R., Hanada T., Aki D., Mashima R., Nishinakamura H., Torisu T., Chien K.R., Yasukawa H., Yoshimura A. Socs3 deficiency in the brain elevates leptin sensitivity and confers resistance to diet-induced obesity. Nat. Med. 2004, 10:739-743.
50. Wanner I.B., Anderson M.A., Song B., Levine J., Fernandez A., Gray-Thompson Z., Ao Y., Sofroniew M.V. Glial scar borders are formed by newly proliferated, elongated astrocytes that interact to corral inflammatory and fibrotic cells via STAT3-dependent mechanisms after spinal cord injury. J. Neurosci. 2013, 33:12870-12886.
51. Renault-Mihara F., Okada S., Shibata S., Nakamura M., Toyama Y., Okano H. Spinal cord injury: emerging beneficial role of reactive astrocytes' migration. Int. J. Biochem. Cell. Biol. 2008, 40:1649-1653.
52. Voskuhl R.R., Peterson R.S., Song B., Ao Y., Morales L.B., Tiwari-Woodruff S., Sofroniew M.V. Reactive astrocytes form scar-like perivascular barriers to leukocytes during adaptive immune inflammation of the CNS. J. Neurosci. 2009, 29:11511-11522.
53. Silver J., Miller J.H. Regeneration beyond the glial scar. Nat. Rev. Neurosci. 2004, 5:146-156.
54. Bush T.G., Puvanachandra N., Horner C.H., Polito A., Ostenfeld T., Svendsen C.N., Mucke L., Johnson M.H., Sofroniew M.V. Leukocyte infiltration, neuronal degeneration, and neurite outgrowth after ablation of scar-forming, reactive astrocytes in adult transgenic mice. Neuron 1999, 23:297-308.
55. Sofroniew M.V., Bush T.G., Blumauer N., Lawrence K., Mucke L., Johnson M.H. Genetically-targeted and conditionally-regulated ablation of astroglial cells in the central, enteric and peripheral nervous systems in adult transgenic mice. Brain Res. 1999, 835:91-95.
56. Faulkner J.R., Herrmann J.E., Woo M.J., Tansey K.E., Doan N.B., Sofroniew M.V. Reactive astrocytes protect tissue and preserve function after spinal cord injury. J. Neurosci. 2004, 24:2143-2155.
57. Garcia A.D., Doan N.B., Imura T., Bush T.G., Sofroniew M.V. GFAP-expressing progenitors are the principal source of constitutive neurogenesis in adult mouse forebrain. Nat. Neurosci. 2004, 7:1233-1241.
58. Eliasson C., Sahlgren C., Berthold C.H., Stakeberg J., Celis J.E., Betsholtz C., Eriksson J.E., Pekny M. Intermediate filament protein partnership in astrocytes. J. Biol. Chem. 1999, 274:23996-24006.
59. Pekny M., Johansson C.B., Eliasson C., Stakeberg J., Wallen A., Perlmann T., Lendahl U., Betsholtz C., Berthold C.H., Frisen J. Abnormal reaction to central nervous system injury in mice lacking glial fibrillary acidic protein and vimentin. J. Cell. Biol. 1999, 145:503-514.
60. Lundkvist A., Reichenbach A., Betsholtz C., Carmeliet P., Wolburg H., Pekny M. Under stress, the absence of intermediate filaments from Muller cells in the retina has structural and functional consequences. J. Cell Sci. 2004, 117:3481-3488.
61. Verardo M.R., Lewis G.P., Takeda M., Linberg K.A., Byun J., Luna G., Wilhelmsson U., Pekny M., Chen D.F., Fisher S.K. Abnormal reactivity of muller cells after retinal detachment in mice deficient in GFAP and vimentin. Invest. Ophthalmol. Vis. Sci. 2008, 49:3659-3665.
62. Hyder C.L., Isoniemi K.O., Torvaldson E.S., Eriksson J.E. Insights into intermediate filament regulation from development to ageing. J. Cell Sci. 2011, 124:1363-1372.
63. Pallari H.M., Eriksson J.E. Intermediate filaments as signaling platforms. Sci. STKE 2006, 2006:pe53.
64. Pekny M., Lane E.B. Intermediate filaments and stress. Exp. Cell Res. 2007, 313:2244-2254.
65. Jing R., Wilhelmsson U., Goodwill W., Li L., Pan Y., Pekny M., Skalli O. Synemin is expressed in reactive astrocytes in neurotrauma and interacts differentially with vimentin and GFAP intermediate filament networks. J. Cell Sci. 2007, 120:1267-1277.
66. Pekny T., Faiz M., Wilhelmsson U., Curtis M.A., Matej R., Skalli O., Pekny M. Synemin is expressed in reactive astrocytes and Rosenthal fibers in Alexander disease. Apmis 2014, 122:76-80.
67. Wilhelmsson U., Li L., Pekna M., Berthold C.H., Blom S., Eliasson C., Renner O., Bushong E., Ellisman M., Morgan T.E., Pekny M. Absence of glial fibrillary acidic protein and vimentin prevents hypertrophy of astrocytic processes and improves post-traumatic regeneration. J. Neurosci. 2004, 24:5016-5021.
68. Li L., Lundkvist A., Andersson D., Wilhelmsson U., Nagai N., Pardo A.C., Nodin C., Stahlberg A., Aprico K., Larsson K., Yabe T., Moons L., Fotheringham A., Davies I., Carmeliet P., Schwartz J.P., Pekna M., Kubista M., Blomstrand F., Maragakis N., Nilsson M., Pekny M. Protective role of reactive astrocytes in brain ischemia. J. Cereb. Blood Flow Metab. 2008, 28:468-481.
69. Wilhelmsson U., Bushong E.A., Price D.L., Smarr B.L., Phung V., Terada M., Ellisman M.H., Pekny M. Redefining the concept of reactive astrocytes as cells that remain within their unique domains upon reaction to injury. Proc. Natl. Acad. Sci. USA 2006, 103:17513-17518.
70. Dietzmann K., von Bossanyi P., Krause D., Wittig H., Mawrin C., Kirches E. Expression of the plasminogen activator system and the inhibitors PAI-1 and PAI-2 in posttraumatic lesions of the CNS and brain injuries following dramatic circulatory arrests: an immunohistochemical study. Pathol. Res. Pract. 2000, 196:15-21.
71. Hultman K., Blomstrand F., Nilsson M., Wilhelmsson U., Malmgren K., Pekny M., Kousted T., Jern C., Tjarnlund-Wolf.A. Expression of plasminogen activator inhibitor-1 and protease nexin-1 in human astrocytes: response to injury-related factors. J. Neurosci. Res. 2010, 88:2441-2449.
72. Jarlestedt K., Rousset C.I., Faiz M., Wilhelmsson U., Stahlberg A., Sourkova H., Pekna M., Mallard C., Hagberg H., Pekny M. Attenuation of reactive gliosis does not affect infarct volume in neonatal hypoxic-ischemic brain injury in mice. PLoS One 2010, 5:e10397.
73. de Pablo Y., Nilsson M., Pekna M., Pekny M. Intermediate filaments are important for astrocyte response to oxidative stress induced by oxygen-glucose deprivation and reperfusion. Histochem. Cell Biol. 2013, 140:81-91.
74. Ding M., Eliasson C., Betsholtz C., Hamberger A., Pekny M. Altered taurine release following hypotonic stress in astrocytes from mice deficient for GFAP and vimentin. Brain Res. Mol. Brain Res. 1998, 62:77-81.
75. Lu Y.B., Iandiev I., Hollborn M., Korber N., Ulbricht E., Hirrlinger P.G., Pannicke T., Wei E.Q., Bringmann A., Wolburg H., Wilhelmsson U., Pekny M., Wiedemann P., Reichenbach A., Kas J.A. Reactive glial cells: increased stiffness correlates with increased intermediate filament expression. FASEB J. 2011, 25:624-631.
76. Potokar M., Kreft M., Li L., Daniel Andersson J., Pangrsic T., Chowdhury H.H., Pekny M., Zorec R. Cytoskeleton and vesicle mobility in astrocytes. Traffic 2007, 8:12-20.
77. Potokar M., Stenovec M., Gabrijel M., Li L., Kreft M., Grilc S., Pekny M., Zorec R. Intermediate filaments attenuate stimulation-dependent mobility of endosomes/lysosomes in astrocytes. Glia 2010, 58:1208-1219.
78. Vardjan N., Gabrijel M., Potokar M., Svajger U., Kreft M., Jeras M., de Pablo Y., Faiz M., Pekny M., Zorec R. IFN-gamma-induced increase in the mobility of MHC class II compartments in astrocytes depends on intermediate filaments. J. Neuroinflamm. 2012, 9:144.
79. Lepekhin E.A., Eliasson C., Berthold C.H., Berezin V., Bock E., Pekny M. Intermediate filaments regulate astrocyte motility. J. Neurochem. 2001, 79:617-625.
80. Kraft A.W., Hu X., Yoon H., Yan P., Xiao Q., Wang Y., Gil S.C., Brown J., Wilhelmsson U., Restivo J.L., Cirrito J.R., Holtzman D.M., Kim J., Pekny M., Lee J.M. Attenuating astrocyte activation accelerates plaque pathogenesis in APP/PS1 mice. FASEB J. 2013, 27:187-198.
81. Macauley S.L., Pekny M., Sands M.S. The role of attenuated astrocyte activation in infantile neuronal ceroid lipofuscinosis. J. Neurosci. 2011, 31:15575-15585.
82. Nakazawa T., Takeda M., Lewis G.P., Cho K.S., Jiao J., Wilhelmsson U., Fisher S.K., Pekny M., Chen D.F., Miller J.W. Attenuated glial reactions and photoreceptor degeneration after retinal detachment in mice deficient in glial fibrillary acidic protein and vimentin. Invest. Ophthalmol. Vis. Sci. 2007, 48:2760-2768.
83. Mrak R.E., Sheng J.G., Griffin W.S. Glial cytokines in Alzheimer's disease: review and pathogenic implications. Hum. Pathol. 1995, 26:816-823.
84. Wyss-Coray.T. Inflammation in Alzheimer disease: driving force, bystander or beneficial response?. Nat. Med. 2006, 12:1005-1015.
85. Wyss-Coray T., Loike J.D., Brionne T.C., Lu E., Anankov R., Yan F., Silverstein S.C., Husemann J. Adult mouse astrocytes degrade amyloid-beta in vitro and in situ. Nat. Med. 2003, 9:453-457.
86. Koistinaho M., Lin S., Wu X., Esterman M., Koger D., Hanson J., Higgs R., Liu F., Malkani S., Bales K.R., Paul S.M. Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-beta peptides. Nat. Med. 2004, 10:719-726.
87. Yin K.J., Cirrito J.R., Yan P., Hu X., Xiao Q., Pan X., Bateman R., Song H., Hsu F.F., Turk J., Xu J., Hsu C.Y., Mills J.C., Holtzman D.M., Lee J.M. Matrix metalloproteinases expressed by astrocytes mediate extracellular amyloid-beta peptide catabolism. J. Neurosci. 2006, 26:10939-10948.
88. Askarova S., Yang X., Sheng W., Sun G.Y., Lee J.C. Role of Abeta-receptor for advanced glycation endproducts interaction in oxidative stress and cytosolic phospholipase A(2) activation in astrocytes and cerebral endothelial cells. Neuroscience 2011, 199:375-385.
89. Armulik A., Genove G., Mae M., Nisancioglu M.H., Wallgard E., Niaudet C., He L., Norlin J., Lindblom P., Strittmatter K., Johansson B.R., Betsholtz C. Pericytes regulate the blood-brain barrier. Nature 2010, 468:557-561.
90. Parpura V., Heneka M.T., Montana V., Oliet S.H., Schousboe A., Haydon P.G., Stout R.F., Spray D.C., Reichenbach A., Pannicke T., Pekny M., Pekna M., Zorec R., Verkhratsky A. Glial cells in (patho)physiology. J. Neurochem. 2012, 121:4-27.
91. Zlokovic B.V. Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders. Nat. Rev. Neurosci. 2011, 12:723-738.
92. Yamaguchi H., Sugihara S., Ogawa A., Saido T.C., Ihara Y. Diffuse plaques associated with astroglial amyloid beta protein, possibly showing a disappearing stage of senile plaques. Acta Neuropathol. 1998, 95:217-222.
93. Hofmann S.L., Das A.K., Lu J.Y., Wisniewski K.E., Gupta P. Infantile neuronal ceroid lipofuscinosis: no longer just a 'Finnish' disease. Eur. J. Paediatr. Neurol. 2001, 5(Suppl A):47-51.
94. Hofmann S.L., Das A.K., Yi W., Lu J.Y., Wisniewski K.E. Genotype-phenotype correlations in neuronal ceroid lipofuscinosis due to palmitoyl-protein thioesterase deficiency. Mol. Genet. Metab. 1999, 66:234-239.
95. Vesa J., Hellsten E., Verkruyse L.A., Camp L.A., Rapola J., Santavuori P., Hofmann S.L., Peltonen L. Mutations in the palmitoyl protein thioesterase gene causing infantile neuronal ceroid lipofuscinosis. Nature 1995, 376:584-587.
96. Gupta P., Soyombo A.A., Atashband A., Wisniewski K.E., Shelton J.M., Richardson J.A., Hammer R.E., Hofmann S.L. Disruption of PPT1 or PPT2 causes neuronal ceroid lipofuscinosis in knockout mice. Proc. Natl. Acad. Sci. USA 2001, 98:13566-13571.
97. Kielar C., Maddox L., Bible E., Pontikis C.C., Macauley S.L., Griffey M.A., Wong M., Sands M.S., Cooper J.D. Successive neuron loss in the thalamus and cortex in a mouse model of infantile neuronal ceroid lipofuscinosis. Neurobiol. Dis. 2007, 25:150-162.
98. Macauley S.L., Wozniak D.F., Kielar C., Tan Y., Cooper J.D., Sands M.S. Cerebellar pathology and motor deficits in the palmitoyl protein thioesterase 1-deficient mouse. Exp. Neurol. 2009, 217:124-135.
99. Laping N.J., Teter B., Nichols N.R., Rozovsky I., Finch C.E. Glial fibrillary acidic protein: regulation by hormones, cytokines, and growth factors. Brain Pathol. 1994, 4:259-275.
100. Schwarz J.M., Bilbo S.D. Sex, glia, and development: interactions in health and disease. Horm. Behav. 2012, 62:243-253.
101. Roemgens A., Singh S., Beyer C., Arnold S. Inducers of chemical hypoxia act in a gender- and brain region-specific manner on primary astrocyte viability and cytochrome C oxidase. Neurotox. Res. 2011, 20:1-14.
102. Santos-Galindo M., Acaz-Fonseca E., Bellini M.J., Garcia-Segura L.M. Sex differences in the inflammatory response of primary astrocytes to lipopolysaccharide. Biol. Sex. Differ. 2011, 2:7.
103. Arnold S., de Araujo G.W., Beyer C. Gender-specific regulation of mitochondrial fusion and fission gene transcription and viability of cortical astrocytes by steroid hormones. J. Mol. Endocrinol. 2008, 41:289-300.
104. Bialas A.R., Stevens B. TGF-beta signaling regulates neuronal C1q expression and developmental synaptic refinement. Nat. Neurosci. 2013, 16:1773-1782.
105. Schafer D.P., Lehrman E.K., Kautzman A.G., Koyama R., Mardinly A.R., Yamasaki R., Ransohoff R.M., Greenberg M.E., Barres B.A., Stevens B. Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner. Neuron 2012, 74:691-705.
106. Stevens B., Allen N.J., Vazquez L.E., Howell G.R., Christopherson K.S., Nouri N., Micheva K.D., Mehalow A.K., Huberman A.D., Stafford B., Sher A., Litke A.M., Lambris J.D., Smith S.J., John S.W., Barres B.A. The classical complement cascade mediates CNS synapse elimination. Cell 2007, 131:1164-1178.
107. Howell G.R., Macalinao D.G., Sousa G.L., Walden M., Soto I., Kneeland S.C., Barbay J.M., King B.L., Marchant J.K., Hibbs M., Stevens B., Barres B.A., Clark A.F., Libby R.T., John S.W. Molecular clustering identifies complement and endothelin induction as early events in a mouse model of glaucoma. J. Clin. Invest. 2011, 121:1429-1444.
108. Stephan A.H., Madison D.V., Mateos J.M., Fraser D.A., Lovelett E.A., Coutellier L., Kim L., Tsai H.H., Huang E.J., Rowitch D.H., Berns D.S., Tenner A.J., Shamloo M., Barres B.A. A dramatic increase of C1q protein in the CNS during normal aging. J. Neurosci. 2013, 33:13460-13474.
109. Beach T.G., Walker R., McGeer.E.G. Patterns of gliosis in Alzheimer's disease and aging cerebrum. Glia 1989, 2:420-436.
110. Alilain W.J., Horn K.P., Hu H., Dick T.E., Silver J. Functional regeneration of respiratory pathways after spinal cord injury. Nature 2011, 475:196-200.
111. Busch S.A., Silver J. The role of extracellular matrix in CNS regeneration. Curr. Opin. Neurobiol. 2007, 17:120-127.
112. Davies S.J., Goucher D.R., Doller C., Silver J. Robust regeneration of adult sensory axons in degenerating white matter of the adult rat spinal cord. J. Neurosci. 1999, 19:5810-5822.
113. Fitch M.T., Silver J. CNS injury, glial scars, and inflammation: Inhibitory extracellular matrices and regeneration failure. Exp. Neurol. 2008, 209:294-301.
114. Goldshmit Y., Galea M.P., Wise G., Bartlett P.F., Turnley A.M. Axonal regeneration and lack of astrocytic gliosis in EphA4-deficient mice. J. Neurosci. 2004, 24:10064-10073.
115. Bradbury E.J., Carter L.M. Manipulating the glial scar: chondroitinase ABC as a therapy for spinal cord injury. Brain Res. Bull. 2011, 84:306-316.
116. Bradbury E.J., Moon L.D., Popat R.J., King V.R., Bennett G.S., Patel P.N., Fawcett J.W., McMahon.S.B. Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature 2002, 416:636-640.
117. Lee H., McKeon R.J., Bellamkonda R.V. Sustained delivery of thermostabilized chABC enhances axonal sprouting and functional recovery after spinal cord injury. Proc. Natl. Acad. Sci. USA 2010, 107:3340-3345.
118. Sharma K., Selzer M.E., Li S. Scar-mediated inhibition and CSPG receptors in the CNS. Exp. Neurol. 2012, 237:370-378.
119. Wang X., Hasan O., Arzeno A., Benowitz L.I., Cafferty W.B., Strittmatter S.M. Axonal regeneration induced by blockade of glial inhibitors coupled with activation of intrinsic neuronal growth pathways. Exp. Neurol. 2012, 237:55-69.
120. Yick L.W., Wu W., So K.F., Yip H.K., Shum D.K. Chondroitinase ABC promotes axonal regeneration of Clarke's neurons after spinal cord injury. Neuroreport 2000, 11:1063-1067.
121. Goldshmit Y., Spanevello M.D., Tajouri S., Li L., Rogers F., Pearse M., Galea M., Bartlett P.F., Boyd A.W., Turnley A.M. EphA4 blockers promote axonal regeneration and functional recovery following spinal cord injury in mice. PLoS One 2011, 6:e24636.
122. Cho K.S., Yang L., Lu B., Feng Ma H., Huang X., Pekny M., Chen D.F. Re-establishing the regenerative potential of central nervous system axons in postnatal mice. J. Cell Sci. 2005, 118:863-872.
123. Menet V., Prieto M., Privat A., Gimenez Ribotta M. Axonal plasticity and functional recovery after spinal cord injury in mice deficient in both glial fibrillary acidic protein and vimentin genes. Proc. Natl. Acad. Sci. USA 2003, 100:8999-9004.
124. Wilhelmsson U., Faiz M., de Pablo Y., Sjoqvist M., Andersson D., Widestrand A., Potokar M., Stenovec M., Smith P.L., Shinjyo N., Pekny T., Zorec R., Stahlberg A., Pekna M., Sahlgren C., Pekny M. Astrocytes negatively regulate neurogenesis through the JAGGED1-mediated notch pathway. Stem Cells 2012, 30:2320-2329.
125. (-/-) mice. Neurochem. Res. 2004, 29:2069-2073.
126. Kinouchi R., Takeda M., Yang L., Wilhelmsson U., Lundkvist A., Pekny M., Chen D.F. Robust neural integration from retinal transplants in mice deficient in GFAP and vimentin. Nat. Neurosci. 2003, 6:863-868.
127. -/- mice. Stem Cells 2007, 25:2619-2627.
128. Myer D.J., Gurkoff G.G., Lee S.M., Hovda D.A., Sofroniew M.V. Essential protective roles of reactive astrocytes in traumatic brain injury. Brain 2006, 129:2761-2772.
129. Sofroniew M.V. Reactive astrocytes in neural repair and protection. Neuroscientist 2005, 11:400-407.
130. Pekny M., Porritt M.J., de Pablo Y., Wilhelmsson U. Reactive Astrocytes, Astrocyte Intermediate Filament Proteins, and Their Role in the Disease Pathogenesis in the Cytoskeleton: Imaging, Isolation, and Interaction 2013, 299-319. Springer Protocols. R. Dermietzel (Ed.).
131. Turner D.A., Buhl E.H., Hailer N.P., Nitsch R. Morphological features of the entorhinal-hippocampal connection. Prog. Neurobiol. 1998, 55:537-562.
132. Chen D.F., Schneider G.E., Martinou J.C., Tonegawa S. Bcl-2 promotes regeneration of severed axons in mammalian CNS. Nature 1997, 385:434-439.
133. Pekny M., Pekna M., Wilhelmsson U., Chen D.F. Astroglia sitting at the controls?. Trends Neurosci. 2004, 27:243-244.
134. Kimelberg H.K., Nedergaard M. Functions of astrocytes and their potential as therapeutic targets. Neurotherapeutics 2010, 7:338-353.
135. Pekna M., Pekny M., Nilsson M. Modulation of neural plasticity as a basis for stroke rehabilitation. Stroke 2012, 43:2819-2828.
136. Lovatt D., Sonnewald U., Waagepetersen H.S., Schousboe A., He W., Lin J.H., Han X., Takano T., Wang S., Sim F.J., Goldman S.A., Nedergaard M. The transcriptome and metabolic gene signature of protoplasmic astrocytes in the adult murine cortex. J. Neurosci. 2007, 27:12255-12266.
137. Cahoy J.D., Emery B., Kaushal A., Foo L.C., Zamanian J.L., Christopherson K.S., Xing Y., Lubischer J.L., Krieg P.A., Krupenko S.A., Thompson W.J., Barres B.A. A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function. J. Neurosci. 2008, 28:264-278.
138. Foo L.C., Allen N.J., Bushong E.A., Ventura P.B., Chung W.S., Zhou L., Cahoy J.D., Daneman R., Zong H., Ellisman M.H., Barres B.A. Development of a method for the purification and culture of rodent astrocytes. Neuron 2011, 71:799-811.
139. Puschmann T.B., de Pablo Y., Zanden C., Liu J., Pekny M. A novel method for 3D culture of central nervous system neurons. Tissue Eng. Part C Methods 2013.
140. Puschmann T.B., Zanden C., De Pablo Y., Kirchhoff F., Pekna M., Liu J., Pekny M. Bioactive 3D cell culture system minimizes cellular stress and maintains the in vivo-like morphological complexity of astroglial cells. Glia 2013, 61:432-440.
141. Puschmann T.B., Zanden C., Lebkuechner I., Philippot C., de Pablo Y., Liu J., Pekny M. HB-EGF affects astrocyte morphology, proliferation, differentiation, and the expression of intermediate filament proteins. J. Neurochem. 2013.
142. Brown C.E., Aminoltejari K., Erb H., Winship I.R., Murphy T.H. In vivo voltage-sensitive dye imaging in adult mice reveals that somatosensory maps lost to stroke are replaced over weeks by new structural and functional circuits with prolonged modes of activation within both the peri-infarct zone and distant sites. J. Neurosci. 2009, 29:1719-1734.
143. Cramer S.C. Repairing the human brain after stroke: I. Mechanisms of spontaneous recovery. Ann. Neurol. 2008, 63:272-287.
144. Overman J.J., Clarkson A.N., Wanner I.B., Overman W.T., Eckstein I., Maguire J.L., Dinov I.D., Toga A.W., Carmichael S.T. A role for ephrin-A5 in axonal sprouting, recovery, and activity-dependent plasticity after stroke. Proc. Natl. Acad. Sci. USA 2012, 109:E2230-E2239.
145. Clarkson A.N., Huang B.S., Macisaac S.E., Mody I., Carmichael S.T. Reducing excessive GABA-mediated tonic inhibition promotes functional recovery after stroke. Nature 2010, 468:305-309.
146. Atack J.R., Bayley P.J., Seabrook G.R., Wafford K.A., McKernan R.M., Dawson G.R. L-655,708 enhances cognition in rats but is not proconvulsant at a dose selective for alpha5-containing GABAA receptors. Neuropharmacology 2006, 51:1023-1029.
147. Oberheim N.A., Tian G.F., Han X., Peng W., Takano T., Ransom B., Nedergaard M. Loss of astrocytic domain organization in the epileptic brain. J. Neurosci. 2008, 28:3264-3276.
148. Wetherington J., Serrano G., Dingledine R. Astrocytes in the epileptic brain. Neuron 2008, 58:168-178.
149. Verkhratsky A., Sofroniew M.V., Messing A., deLanerolle N.C., Rempe D., Rodriguez J.J., Nedergaard M. Neurological diseases as primary gliopathies: a reassessment of neurocentrism. Am. Soc. Nuerochem. NEURO 2012, 4:e00082.
150. Seifert G., Carmignoto G., Steinhauser C. Astrocyte dysfunction in epilepsy. Brain Res. Rev. 2010, 63:212-221.
151. Carmignoto G., Haydon P.G. Astrocyte calcium signaling and epilepsy. Glia 2012, 60:1227-1233.
152. Aronica E., Ravizza T., Zurolo E., Vezzani A. Astrocyte immune responses in epilepsy. Glia 2012, 60:1258-1268.
153. Tian G.F., Azmi H., Takano T., Xu Q., Peng W., Lin J., Oberheim N., Lou N., Wang X., Zielke H.R., Kang J., Nedergaard M. An astrocytic basis of epilepsy. Nat. Med. 2005, 11:973-981.
154. Ortinski P.I., Dong J., Mungenast A., Yue C., Takano H., Watson D.J., Haydon P.G., Coulter D.A. Selective induction of astrocytic gliosis generates deficits in neuronal inhibition. Nat. Neurosci. 2010, 13:584-591.
155. Brenner M., Johnson A.B., Boespflug-Tanguy O., Rodriguez D., Goldman J.E., Messing A. Mutations in GFAP, encoding glial fibrillary acidic protein, are associated with Alexander disease. Nat. Genet. 2001, 27:117-120.
156. Cho W., Brenner M., Peters N., Messing A. Drug screening to identify suppressors of GFAP expression. Hum. Mol. Genet. 2010, 19:3169-3178.
157. Rothstein J.D., Patel S., Regan M.R., Haenggeli C., Huang Y.H., Bergles D.E., Jin L., Dykes Hoberg M., Vidensky S., Chung D.S., Toan S.V., Bruijn L.I., Su Z.Z., Gupta P., Fisher P.B. Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature 2005, 433:73-77.
158. Lipton S.A., Gu Z., Nakamura T. Inflammatory mediators leading to protein misfolding and uncompetitive/fast off-rate drug therapy for neurodegenerative disorders. Int. Rev. Neurobiol. 2007, 82:1-27.
159. Nilsson M., Pekny M. Enriched environment and astrocytes in central nervous system regeneration. J. Rehabil. Med. 2007, 39:345-352.
160. Enge M., Wilhelmsson U., Abramsson A., Stakeberg J., Kuhn R., Betsholtz C., Pekny M. Neuron-specific ablation of PDGF-B is compatible with normal central nervous system development and astroglial response to injury. Neurochem. Res. 2003, 28:271-279.